Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 203

1.

Simultaneous down-regulation of tumor suppressor genes RBSP3/CTDSPL, NPRL2/G21 and RASSF1A in primary non-small cell lung cancer.

Senchenko VN, Anedchenko EA, Kondratieva TT, Krasnov GS, Dmitriev AA, Zabarovska VI, Pavlova TV, Kashuba VI, Lerman MI, Zabarovsky ER.

BMC Cancer. 2010 Mar 1;10:75. doi: 10.1186/1471-2407-10-75.

2.

[Down-regulation of RBSP3/CTDSPL, NPRL2/G21, RASSF1A, ITGA9, HYAL1 and HYAL2 genes in non-small cell lung cancer].

Anedchenko EA, Dmitriev AA, Krasnov GS, Kondrat'eva TT, Kopantsev EP, Vinogradova TV, Zinov'eva MV, Zborovskaia IB, Polotskiĭ BE, Sakharova OV, Kashuba VI, Zabarovskiĭ ER, Senchenko VN.

Mol Biol (Mosk). 2008 Nov-Dec;42(6):965-76. Russian.

PMID:
19140316
3.

Quantitative analysis of mRNA expression levels and DNA methylation profiles of three neighboring genes: FUS1, NPRL2/G21 and RASSF1A in non-small cell lung cancer patients.

Pastuszak-Lewandoska D, Kordiak J, Migdalska-Sęk M, Czarnecka KH, Antczak A, Górski P, Nawrot E, Kiszałkiewicz JM, Domańska D, Brzeziańska-Lasota E.

Respir Res. 2015 Jun 26;16:76. doi: 10.1186/s12931-015-0230-6.

4.

Novel tumor suppressor candidates on chromosome 3 revealed by NotI-microarrays in cervical cancer.

Senchenko VN, Kisseljova NP, Ivanova TA, Dmitriev AA, Krasnov GS, Kudryavtseva AV, Panasenko GV, Tsitrin EB, Lerman MI, Kisseljov FL, Kashuba VI, Zabarovsky ER.

Epigenetics. 2013 Apr;8(4):409-20. doi: 10.4161/epi.24233. Epub 2013 Mar 11.

5.

Genetic and epigenetic analysis of non-small cell lung cancer with NotI-microarrays.

Dmitriev AA, Kashuba VI, Haraldson K, Senchenko VN, Pavlova TV, Kudryavtseva AV, Anedchenko EA, Krasnov GS, Pronina IV, Loginov VI, Kondratieva TT, Kazubskaya TP, Braga EA, Yenamandra SP, Ignatjev I, Ernberg I, Klein G, Lerman MI, Zabarovsky ER.

Epigenetics. 2012 May;7(5):502-13. doi: 10.4161/epi.19801. Epub 2012 May 1.

PMID:
22491060
6.

Functional characterization of the candidate tumor suppressor gene NPRL2/G21 located in 3p21.3C.

Li J, Wang F, Haraldson K, Protopopov A, Duh FM, Geil L, Kuzmin I, Minna JD, Stanbridge E, Braga E, Kashuba VI, Klein G, Lerman MI, Zabarovsky ER.

Cancer Res. 2004 Sep 15;64(18):6438-43.

7.

Frequent 3p allele loss and epigenetic inactivation of the RASSF1A tumour suppressor gene from region 3p21.3 in head and neck squamous cell carcinoma.

Hogg RP, Honorio S, Martinez A, Agathanggelou A, Dallol A, Fullwood P, Weichselbaum R, Kuo MJ, Maher ER, Latif F.

Eur J Cancer. 2002 Aug;38(12):1585-92.

PMID:
12142046
8.

Methylation associated inactivation of RASSF1A from region 3p21.3 in lung, breast and ovarian tumours.

Agathanggelou A, Honorio S, Macartney DP, Martinez A, Dallol A, Rader J, Fullwood P, Chauhan A, Walker R, Shaw JA, Hosoe S, Lerman MI, Minna JD, Maher ER, Latif F.

Oncogene. 2001 Mar 22;20(12):1509-18.

9.

Frequent inactivation of RASSF1A, BLU, and SEMA3B on 3p21.3 by promoter hypermethylation and allele loss in non-small cell lung cancer.

Ito M, Ito G, Kondo M, Uchiyama M, Fukui T, Mori S, Yoshioka H, Ueda Y, Shimokata K, Sekido Y.

Cancer Lett. 2005 Jul 8;225(1):131-9. Epub 2004 Dec 22.

PMID:
15922865
10.

Identification of novel gene expression targets for the Ras association domain family 1 (RASSF1A) tumor suppressor gene in non-small cell lung cancer and neuroblastoma.

Agathanggelou A, Bièche I, Ahmed-Choudhury J, Nicke B, Dammann R, Baksh S, Gao B, Minna JD, Downward J, Maher ER, Latif F.

Cancer Res. 2003 Sep 1;63(17):5344-51.

11.

Promoter hypermethylation of RASSF1A and RUNX3 genes as an independent prognostic prediction marker in surgically resected non-small cell lung cancers.

Yanagawa N, Tamura G, Oizumi H, Kanauchi N, Endoh M, Sadahiro M, Motoyama T.

Lung Cancer. 2007 Oct;58(1):131-8. Epub 2007 Jul 2.

PMID:
17606310
13.

Frequent epigenetic inactivation of RASSF1A in human bladder carcinoma.

Lee MG, Kim HY, Byun DS, Lee SJ, Lee CH, Kim JI, Chang SG, Chi SG.

Cancer Res. 2001 Sep 15;61(18):6688-92.

14.

Epigenetic inactivation of the candidate 3p21.3 suppressor gene BLU in human cancers.

Agathanggelou A, Dallol A, Zöchbauer-Müller S, Morrissey C, Honorio S, Hesson L, Martinsson T, Fong KM, Kuo MJ, Yuen PW, Maher ER, Minna JD, Latif F.

Oncogene. 2003 Mar 13;22(10):1580-8.

PMID:
12629521
16.
17.

Inactivation of RAS association domain family 1A gene in cervical carcinomas and the role of human papillomavirus infection.

Kuzmin I, Liu L, Dammann R, Geil L, Stanbridge EJ, Wilczynski SP, Lerman MI, Pfeifer GP.

Cancer Res. 2003 Apr 15;63(8):1888-93.

18.

Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3.

Dammann R, Li C, Yoon JH, Chin PL, Bates S, Pfeifer GP.

Nat Genet. 2000 Jul;25(3):315-9.

PMID:
10888881
19.

Hypermethylation-modulated downregulation of RASSF1A expression is associated with the progression of esophageal cancer.

Mao WM, Li P, Zheng QQ, Wang CC, Ge MH, Hu FJ, Fang XH, Dong ZM, Ling ZQ.

Arch Med Res. 2011 Apr;42(3):182-8. doi: 10.1016/j.arcmed.2011.04.002.

PMID:
21722812
20.

RASSF1A gene inactivation in non-small cell lung cancer and its clinical implication.

Endoh H, Yatabe Y, Shimizu S, Tajima K, Kuwano H, Takahashi T, Mitsudomi T.

Int J Cancer. 2003 Aug 10;106(1):45-51.

Supplemental Content

Support Center